Benzinga's Top Upgrades, Downgrades For March 5, 2019

Top Upgrades

  • Morgan Stanley upgraded Alnylam Pharmaceuticals, Inc. ALNY from Equal-Weight to Overweight. Alnylam Pharmaceuticals shares rose 3.7 percent to $88.10 in pre-market trading.
  • Macquarie upgraded Encana Corp ECA from Neutral to Outperform. Encana shares rose 0.6 percent to $7.28 in pre-market trading.
  • Bank of America upgraded Veritiv Corp VRTV from Neutral to Buy. Veritiv shares fell 1.89 percent to close at $26.94 on Monday.
  • JP Morgan upgraded Ctrip.Com International Ltd CTRP from Neutral to Overweight. Ctrip.com shares rose 11.4 percent to $38.96 in pre-market trading.
  • Morgan Stanley upgraded ImmunoGen, Inc. IMGN from Underweight to Equal-Weight. Immunogen shares rose 3.1 percent to $2.68 in pre-market trading.
  • JP Morgan upgraded TPI Composites Inc TPIC from Neutral to Overweight. TPI Composites shares fell 4.11 percent to close at $27.50 on Monday.

 

Top Downgrades

  • Seaport Global downgraded Spirit AeroSystems Holdings, Inc. SPR from Buy to Neutral. Spirit AeroSystems shares fell 0.71 percent to close at $98.64 on Monday.
  • DA Davidson downgraded Inter Parfums, Inc. IPAR from Buy to Neutral. Inter Parfums shares closed at $76.80 on Monday.
  • H.C. Wainwright downgraded Evoke Pharma Inc EVOK from Buy to Neutral. Evoke Pharma shares rose 2.3 percent to $1.33 in pre-market trading.
  • Stifel Nicolaus downgraded Bluegreen Vacations Corp BXG from Buy to Hold. Bluegreen Vacations shares fell 1 percent to $15.61 in pre-market trading.
  • Leerink Swann downgraded bluebird bio Inc BLUE from Outperform to Market Perform. bluebird shares fell 1.9 percent to $150.00 in pre-market trading.
  • SVB Leerink downgraded Nightstar Therapeutics PLC NITE from Outperform to Market Perform. Nightstar Therapeutics shares closed at $25.18 on Monday.
  • Cowen & Co. downgraded Adamas Pharmaceuticals Inc ADMS from Outperform to Market Perform. Adamas Pharmaceuticals shares fell 34.2 percent to $8.00 in pre-market trading.
  • Wells Fargo downgraded Uniti Group Inc UNIT from Market Perform to Underperform. Uniti shares fell 8.1 percent to $8.73 in pre-market trading.
  • Mizuho downgraded Nightstar Therapeutics PLC NITE from Buy to Neutral. Nightstar Therapeutics shares closed at $25.18 on Monday.

 

Top Initiations

  • SVB Leerink initiated coverage on Gossamer Bio Inc GOSS with an Outperform rating. Gossamer Bio shares closed at $22.83 on Monday.
  • Analysts at Jefferies initiated coverage on Marinus Pharmaceuticals Inc MRNS with a Buy rating. The price target for Marinus Pharmaceuticals is set to $10. Marinus Pharmaceuticals shares closed at $3.56 on Monday.
  • Stephens & Co. initiated coverage on Tyson Foods, Inc. TSN with an Overweight rating. Tyson shares closed at $62.26 on Monday.
  • Needham initiated coverage on Alphabet Inc GOOGL with a Buy rating. The price target for Alphabet is set to $1,350. Alphabet shares closed at $1,153.42 on Monday.
  • Goldman Sachs initiated coverage on Lennox International Inc. LII with a Neutral rating. The price target for Lennox is set to $236. Lennox shares closed at $245.41 on Monday.
  • Analysts at Stephens & Co. initiated coverage on Pilgrim's Pride Corporation PPC with an Overweight rating. The price target for Pilgrim's Pride is set to $26. Pilgrim's Pride shares closed at $19.75 on Monday.
  • Cowen & Co. initiated coverage on Heico Corp HEI with a Market Perform rating. The price target for Heico is set to $95. Heico shares closed at $93.10 on Monday.
  • Oppenheimer initiated coverage on Arcosa Inc ACA with an Outperform rating. The price target for Arcosa is set to $40. Arcosa shares closed at $34.88 on Monday.
  • Analysts at Cantor Fitzgerald initiated coverage on Mirati Therapeutics Inc MRTX with a Neutral rating. Mirati Therapeutics shares closed at $72.93 on Monday.
  • Analysts at Baird initiated coverage on Floor & Decor Holdings Inc FND with an Outperform rating. The price target for Floor & Decor is set to $48. Floor & Decor shares closed at $38.10 on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsBuilding ProductsFinancialsIndustrialsInitiationsInvestment Banking & Brokeragetop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!